Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 04, 2021 at 06:48 pm EDT
Share
SYN-TECH Chem. & Pharm. Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 216.335 million compared to TWD 305.145 million a year ago. Operating income was TWD 41.152 million compared to TWD 99.653 million a year ago. Net income was TWD 22.249 million compared to TWD 70.718 million a year ago. Basic earnings per share was TWD 0.74 compared to TWD 2.35 a year ago. For the half year, sales was TWD 451.918 million compared to TWD 540.472 million a year ago. Operating income was TWD 104.780 million compared to TWD 151.522 million a year ago. Net income was TWD 74.221 million compared to TWD 117.608 million a year ago. Basic earnings per share was TWD 2.47 compared to TWD 3.91 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
